Data on adverse events and efficacy were evaluated twice yearly by an independent data and safety monitoring board with predefined stopping rules. Results Participants in this study were relatives of patients with type 1 diabetes who tested positive for multiple autoantibodies and had normal glucose ...
Data on adverse events and efficacy were evaluated twice yearly by an independent data and safety monitoring board with predefined stopping rules. Results Participants in this study were relatives of patients with type 1 diabetes who tested positive for multiple autoantibodies and had normal glucose ...